SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 223 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $274,294 | +17.8% | 9,949 | +28.4% | 0.00% | 0.0% |
| Q2 2023 | $232,845 | -2.5% | 7,746 | +17.5% | 0.00% | 0.0% |
| Q1 2023 | $238,901 | -9.7% | 6,594 | -11.1% | 0.00% | 0.0% |
| Q4 2022 | $264,600 | -11.5% | 7,418 | -16.0% | 0.00% | -50.0% |
| Q3 2022 | $299,000 | +17.3% | 8,827 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $255,000 | -11.5% | 8,827 | -1.0% | 0.00% | 0.0% |
| Q1 2022 | $288,000 | -5.6% | 8,912 | -14.9% | 0.00% | 0.0% |
| Q4 2021 | $305,000 | +88.3% | 10,469 | +72.8% | 0.00% | 0.0% |
| Q3 2021 | $162,000 | -13.4% | 6,060 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $187,000 | +17.6% | 6,060 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $159,000 | +4.6% | 6,060 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $152,000 | +20.6% | 6,060 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $126,000 | -12.5% | 6,060 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $144,000 | +67.4% | 6,060 | +27.2% | 0.00% | 0.0% |
| Q1 2020 | $86,000 | +19.4% | 4,765 | +56.8% | 0.00% | 0.0% |
| Q4 2019 | $72,000 | -14.3% | 3,039 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $84,000 | -16.8% | 3,039 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $101,000 | -4.7% | 3,039 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $106,000 | -15.2% | 3,039 | -19.1% | 0.00% | 0.0% |
| Q4 2018 | $125,000 | -33.9% | 3,756 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $189,000 | -16.0% | 3,756 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $225,000 | +37.2% | 3,756 | +5.2% | 0.00% | +100.0% |
| Q1 2018 | $164,000 | +15.5% | 3,572 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $142,000 | +17.4% | 3,572 | +18.4% | 0.00% | 0.0% |
| Q3 2017 | $121,000 | -6.9% | 3,018 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $130,000 | +420.0% | 3,018 | +278.2% | 0.00% | – |
| Q1 2017 | $25,000 | +25.0% | 798 | 0.0% | 0.00% | – |
| Q4 2016 | $20,000 | 0.0% | 798 | 0.0% | 0.00% | – |
| Q3 2016 | $20,000 | +81.8% | 798 | +47.8% | 0.00% | – |
| Q2 2016 | $11,000 | +37.5% | 540 | 0.0% | 0.00% | – |
| Q1 2016 | $8,000 | +14.3% | 540 | 0.0% | 0.00% | – |
| Q4 2015 | $7,000 | -12.5% | 540 | 0.0% | 0.00% | – |
| Q3 2015 | $8,000 | – | 540 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |